Innovative technology fails in the market more often than it fails in the lab.

We advise technology companies entering new markets — across borders, categories, and buyer segments — and the failures in this collection are not academic to us. Every cause of death in the taxonomy is a decision a founder or GTM leader made, reasonably, with the information available at the time. The museum exists because the pattern is more visible in hindsight, across many exhibits, than it ever is in the middle of a single launch.

This is deliberately not a mockery site. Every exhibit opens by establishing what was genuinely innovative about the technology, because the interesting failures — the ones worth studying — are the ones where the product worked and the market still said no. Companies here are analyzed for a market entry decision, not ridiculed as people or teams; fraud and active litigation are explicitly out of scope.

The cause-of-death analysis in each exhibit is our editorial read of the public record, not an assertion of settled fact — we say so explicitly in the text. Facts (dates, prices, funding figures) are sourced; the argument about why something failed is ours, and it's meant to be argued with, not just accepted.